Ventas cene 650 milijonov Cdn $ 5.10 % starejših obveznic, ki zapadejo v plačilo 2029

CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (»Ventas« ali »podjetje«) je danes sporočil, da je zasebno ponudbo v Kanadi ocenil na 650 Cdn$ milijonov 5.10 % višjih obveznic serije J z zapadlostjo 2029 (»obveznice«). Prodaja Obveznic se bo predvidoma zaključila 5. marca 2024, če bodo izpolnjeni običajni zaključni pogoji.

Obveznice izda Ventasova posredna hčerinska družba v 100-odstotni lasti Ventas Canada Finance Limited (»izdajatelj«) na podlagi izvzetja iz prospekta samo za »pooblaščene vlagatelje«, ki niso posamezniki, razen če so ti posamezniki tudi »dovoljene stranke«. ,« v vsakem primeru, kot je opredeljeno v veljavni kanadski zakonodaji o vrednostnih papirjih. Družba bo brezpogojno jamčila za Obveznice (»jamstvo«).

Dolžnice bodo zapadle 5. marca 2029. Dolžnice bodo predstavljale prednostne nezavarovane obveznosti izdajatelja in bodo enakovredne vsem drugim sedanjim in prihodnjim nezavarovanim in nepodrejenim obveznostim izdajatelja. Jamstvo bo predstavljalo nadrejeno nezavarovano obveznost Poroka in bo enakovredna vsem drugim sedanjim in prihodnjim nezavarovanim in nepodrejenim obveznostim Družbe. Obresti na dolžniške vrednostne papirje bodo plačane polletno za nazaj 5. marca in 5. septembra vsako leto, z začetkom 5. septembra 2024. Pričakuje se, da bodo dolžniške vrednostne papirje ocenili BBB+ (stabilno) s strani S&P, Baa1 (stabilno) s strani Moody's in BBB (stabilen) s strani Fitch.

Izdajatelj namerava uporabiti čisti izkupiček od ponudbe Obveznic za odplačilo neporavnanih zneskov v okviru obstoječe zadolženosti izdajatelja, vključno z njegovim nezavarovanim posojilom v višini 500 milijonov Cdn$, in za druge splošne namene podjetja.

Dolžnice niso bile in ne bodo registrirane v skladu z Zakonom o vrednostnih papirjih iz leta 1933, kakor je bil spremenjen (»Zakon o vrednostnih papirjih«) ali kateri koli državnim zakonom o vrednostnih papirjih in jih ni dovoljeno ponujati ali prodajati v Združenih državah brez registracije ali veljavne izjeme od zahteve za registracijo zakona o vrednostnih papirjih in veljavnih državnih zakonov. Dolžnice niso bile kvalificirane s prospektom v nobeni provinci ali ozemlju Kanade in jih ni dovoljeno ponuditi ali prodati osebam, ki se nahajajo ali prebivajo v Kanadi, razen v skladu z izjemo od zahtev glede prospekta veljavne kanadske zakonodaje o vrednostnih papirjih.

To sporočilo za javnost ne predstavlja ponudbe za prodajo ali nakup ali nagovarjanja k ponudbi za nakup ali prodajo katerega koli vrednostnega papirja in ne predstavlja ponudbe, nagovarjanja, prodaje ali nakupa kakršnih koli vrednostnih papirjev v kateri koli jurisdikciji, v kateri je taka ponudba, nagovarjanje, prodaja ali bi bil nakup nezakonit.

Ventas Inc. (NYSE:VTR) je vodilni sklad za naložbe v nepremičnine S&P 500, osredotočen na zagotavljanje močnih, trajnostnih donosov delničarjem z omogočanjem izjemnih okolij, ki koristijo velikemu in naraščajočemu starajočemu se prebivalstvu. Rast podjetja spodbujajo njegove stanovanjske skupnosti za starejše, ki prebivalcem zagotavljajo dragocene storitve in jim omogočajo, da uspevajo v podprtih okoljih. Ventas izkorišča svoje neprimerljivo operativno strokovno znanje in vpoglede, ki temeljijo na podatkih iz Ventas Operational Insights^TM platformo, obsežnimi odnosi in močnim finančnim položajem, da doseže svoj cilj zagotavljanja izjemne uspešnosti v približno 1,400 nepremičninah. Portfelj Ventas sestavljajo stanovanjske skupnosti za starejše, ambulantne zdravstvene zgradbe, raziskovalni centri in zdravstvene ustanove v Severni Ameriki in Združenem kraljestvu. Podjetje ima koristi od izkušene ekipe nadarjenih strokovnjakov, ki si delijo predanost odličnosti, integriteti in skupnemu namenu pomagati ljudem živeti dlje, bolj zdravo in srečnejše.

To sporočilo za javnost vključuje izjave o prihodnosti v smislu razdelka 27A zakona o vrednostnih papirjih in razdelka 21E zakona o borzi vrednostnih papirjev iz leta 1934, kot je bil spremenjen, in informacije o prihodnosti v smislu veljavne kanadske zakonodaje o vrednostnih papirjih (skupaj »napoved -vidne izjave«). Te izjave o prihodnosti med drugim vključujejo izjave o pričakovanjih, prepričanjih, prihodnjih načrtih in strategijah, pričakovanih rezultatih poslovanja in razvoja ter drugih zadevah, ki niso zgodovinska dejstva. V prihodnost usmerjene izjave med drugim vključujejo izjave o našem namenu in namenu, prepričanju ali pričakovanju naših uradnikov, kot je opredeljeno z uporabo besed, kot so »domnevam«, »lahko«, »bo«, »predvidevam«, »pričakujem, ” “verjeti,” “nameravati,” “predvideti,” “iskati,” “cilj,” “napoved,” “načrt,” “potencial,” “priložnost,” “ocena,” “lahko,” “bi,” “ naj« in drugi primerljivi in ​​izpeljani izrazi ali negativni izrazi iz njih.

Izjave o prihodnosti temeljijo na prepričanju vodstva kot tudi na številnih predpostavkah v zvezi s prihodnjimi dogodki. Ne smete se pretirano zanašati na te napovedne izjave, ki niso jamstvo za uspešnost in so podvržene številnim negotovostim in drugim dejavnikom, ki bi lahko povzročili, da se dejanski dogodki ali rezultati bistveno razlikujejo od tistih, ki so izraženi ali implicirani v videti izjave. Ne prevzemamo dolžnosti posodabljanja teh napovednih izjav, ki govorijo le o datumu, ko so bile podane. Pozivamo vas, da natančno pregledate razkritja, ki jih podajamo v zvezi s tveganji in negotovostmi, ki lahko vplivajo na naše poslovanje in prihodnjo finančno uspešnost, vključno s tistimi spodaj in v naših vlogah pri Komisiji za vrednostne papirje in borzo, na primer v razdelkih z naslovom »Opozorilne izjave – povzetek dejavnikov tveganja«, »Dejavniki tveganja« in »Razprava in analiza vodstva o finančnem stanju in rezultatih poslovanja« v našem Letno poročilo na obrazcu 10-K za leto, ki se je končalo 31. decembra 2023.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments of properties, including our ownership of the properties included in our equitized loan portfolio; (b) our exposure and the exposure of our tenants, managers and borrowers to complex healthcare and other regulation, including evolving laws and regulations regarding data privacy and cybersecurity and environmental matters, and the challenges and expense associated with complying with such regulation; (c) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, managers or borrowers to increased operating costs, uninsured liabilities, fines or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (d) the impact of market and general economic conditions on us, our tenants, managers and borrowers and in areas in which our properties are geographically concentrated, including macroeconomic trends and financial market events, such as bank failures and other events affecting financial institutions, market volatility, increases in inflation, changes in or elevated interest and exchange rates, tightening of lending standards and reduced availability of credit or capital, geopolitical conditions, supply chain pressures, rising labor costs and historically low unemployment, events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets, labor markets and public and private capital markets; (e) our reliance and the reliance of our tenants, managers and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained, including as a result of bank failures or concerns or rumors about such events, tightening of lending standards and reduced availability of credit or capital; (f) the secondary and tertiary effects of the COVID-19 pandemic on our business, financial condition and results of operations and the implementation and impact of regulations related to the CARES Act and other stimulus legislation, including the risk that some or all of the CARES Act or other COVID-19 relief payments we or our tenants, managers or borrowers received could be recouped; (g) our ability, and the ability of our tenants, managers and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, and the financial condition or business prospect of our tenants, managers and borrowers; (h) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our tenants, managers, borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us, which could have an adverse impact on our results of operations and financial condition; (i) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (j) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries’ existing indebtedness; (k) the recognition of reserves, allowances, credit losses or impairment charges are inherently uncertain, may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets, which could have an adverse impact on our results of operations and financial condition; (l) the non-renewal of any leases or management agreement or defaults by tenants or managers thereunder and the risk of our inability to replace those tenants or managers on a timely basis or on favorable terms, if at all; (m) our ability to identify and consummate future investments in or dispositions of healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests, including our ability to dispose of such assets on favorable terms as a result of rights of first offer or rights of first refusal in favor of third parties; (n) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (o) our ability to attract and retain talented employees; (p) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (q) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; (r) the risk of changes in healthcare law or regulation or in tax laws, guidance and interpretations, particularly as applied to REITs, that could adversely affect us or our tenants, managers or borrowers; (s) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (t) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for or rent from us, which limits our control and influence over such operations and results; (u) our exposure to various operational risks, liabilities and claims from our operating assets; (v) our dependency on a limited number of tenants and managers for a significant portion of our revenues and operating income; (w) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the real estate industry, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (x) the risk of damage to our reputation; (y) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our tenants, managers or other counterparties; (z) the risk of exposure to unknown liabilities from our investments in properties or businesses; (aa) the occurrence of cybersecurity threats and incidents that could disrupt our or our tenants’, managers’ or borrower’s operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (bb) the failure to maintain effective internal controls, which could harm our business, results of operations and financial condition; (cc) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our tenants, managers or borrowers; (dd) disruptions to the management and operations of our business and the uncertainties caused by activist investors; (ee) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change; (ff) the risk of potential dilution resulting from future sales or issuances of our equity securities; and (gg) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

Kontakti

Ventas, Inc.

BJ Grant

(877) 4-VENTAS

• Distribucija vsebine in PR s pomočjo SEO. Okrepite se še danes.
• PlatoData.Network Vertical Generative Ai. Opolnomočite se. Dostopite tukaj.
• PlatoAiStream. Web3 Intelligence. Razširjeno znanje. Dostopite tukaj.
• PlatoESG. Ogljik, CleanTech, Energija, Okolje, sončna energija, Ravnanje z odpadki. Dostopite tukaj.
• PlatoHealth. Obveščanje o biotehnologiji in kliničnih preskušanjih. Dostopite tukaj.
• vir: https://www.fintechnews.org/ventas-prices-cdn650-million-of-5-10-senior-notes-due-2029/